Cargando…

Pentoxifylline Reverses Chronic Experimental Chagasic Cardiomyopathy in Association with Repositioning of Abnormal CD8(+) T-Cell Response

BACKGROUND: Chronic chagasic cardiomyopathy (CCC), the main clinical sign of Chagas disease, is associated with systemic CD8(+) T-cell abnormalities and CD8-enriched myocarditis occurring in an inflammatory milieu. Pentoxifylline (PTX), a phosphodiesterase inhibitor, has immunoregulatory and cardiop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Isabela Resende, Vilar-Pereira, Glaucia, Moreira, Otacilio Cruz, Ramos, Isalira Peroba, Gibaldi, Daniel, Britto, Constança, Moraes, Milton Ozório, Lannes-Vieira, Joseli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366205/ https://www.ncbi.nlm.nih.gov/pubmed/25789471 http://dx.doi.org/10.1371/journal.pntd.0003659

Ejemplares similares

Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy
por: Gibaldi, Daniel, et al.
Publicado: (2020)

Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy
por: Silva Grijó Farani, Priscila, et al.
Publicado: (2023)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2021)

Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2021)

Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease
por: Pedra-Rezende, Yasmin, et al.
Publicado: (2021)

Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas’ Heart Disease: Antagonistic Participation of CCR1(+) and CCR5(+) Cells in Chronic Chagasic Cardiomyopathy
por: Batista, Angelica Martins, et al.
Publicado: (2018)

A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Re-programs Immune Response and Reverses Chronic Cardiomyopathy
por: Pereira, Isabela Resende, et al.
Publicado: (2015)

Role of FAK signaling in chagasic cardiac hypertrophy
por: Tucci, Amanda R., et al.
Publicado: (2020)

Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu
por: Silva, Andrea Alice, et al.
Publicado: (2017)

Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies
por: da Matta, José Alberto Martins, et al.
Publicado: (2012)

Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2022)

Genetic Ablation and Pharmacological Blockade of Bradykinin B1 Receptor Unveiled a Detrimental Role for the Kinin System in Chagas Disease Cardiomyopathy
por: Oliveira, Ana Carolina, et al.
Publicado: (2023)

Analysis of Iron Metabolism in Chronic Chagasic Cardiomyopathy
por: Miranda, Carla Paixão, et al.
Publicado: (2019)

Clinical and Echocardiographic Predictors of Mortality in Chagasic Cardiomyopathy - Systematic Review
por: Pereira, Clodoval de Barros, et al.
Publicado: (2014)

Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2015)

Inducible Nitric Oxide Synthase in Heart Tissue and Nitric Oxide in Serum of Trypanosoma cruzi-Infected Rhesus Monkeys: Association with Heart Injury
por: Carvalho, Cristiano Marcelo Espinola, et al.
Publicado: (2012)

Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved(*)
por: Lannes-Vieira, Joseli, et al.
Publicado: (2023)

Echocardiographic Measurements in a Preclinical Model of Chronic Chagasic Cardiomyopathy in Dogs: Validation and Reproducibility
por: Carvalho, Eduardo B., et al.
Publicado: (2019)

CD8(+) T-Cells Expressing Interferon Gamma or Perforin Play Antagonistic Roles in Heart Injury in Experimental Trypanosoma Cruzi-Elicited Cardiomyopathy
por: Silverio, Jaline Coutinho, et al.
Publicado: (2012)

Stem Cell-Based Therapies in Chagasic Cardiomyopathy
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2015)

Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)

Selenium Treatment and Chagasic Cardiopathy (STCC): study protocol for a double-blind randomized controlled trial
por: Alvarenga Americano do Brasil, Pedro Emmanuel, et al.
Publicado: (2014)

Electrophysiological study in chagasics with syncope and conduction disorder
por: Dreicon, Alexia Hallack, et al.
Publicado: (2023)

Chagasic Cardiomyopathy in Immigrants from Latin America to Spain
por: Pérez de Ayala, Ana, et al.
Publicado: (2009)

Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy
por: Fragata, Claudia da Silva, et al.
Publicado: (2015)

Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from Brazil
por: Alvarado-Arnez, Lucia Elena, et al.
Publicado: (2018)

Effects of Cholinergic Stimulation with Pyridostigmine Bromide on Chronic Chagasic Cardiomyopathic Mice
por: de Cuba, Marília Beatriz, et al.
Publicado: (2014)

A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
por: Holanda, Marcelo Teixeira, et al.
Publicado: (2018)

Chagasic cardiomyopathy is marked by a unique signature of activated CD4(+) T cells
por: Almeida, Gregório Guilherme, et al.
Publicado: (2022)

MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes
por: Navarro, Isabela Cunha, et al.
Publicado: (2015)

Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach(*)
por: Lannes-Vieira, Joseli
Publicado: (2022)

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
por: Muratore, Claudio A, et al.
Publicado: (2010)

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2019)

Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19
por: Maldonado, Valente, et al.
Publicado: (2020)

Trypanosoma cruzi activates mouse cardiac fibroblasts in vitro leading to fibroblast-myofibroblast transition and increase in expression of extracellular matrix proteins
por: Coelho, Laura Lacerda, et al.
Publicado: (2018)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
por: Brasil, Guilherme Visconde, et al.
Publicado: (2020)

Cardiovascular Magnetic Resonance Imaging Evidence of Edema in Chronic Chagasic Cardiomyopathy
por: Diaz, Andrés, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ctadcg6qsmlvmj0rce89f6dk4s